Document is current
Any future updates will be listed below
-
Authors
Fonseca, Marlene https://orcid.org/0009-0000-5828-8535
Bauzà Valverde, Gabriel
Bendarraz, Abdelkarim
Catalán Flores, Carmen https://orcid.org/0009-0004-8263-7167
Sharma, Vikas Mohan
-
Funding
Funding for this research was provided by:
Neuraxpharm
- License Information
-
More Information
Article History
Received: 3 October 2025
Accepted: 10 November 2025
First Online: 23 November 2025
Declarations
:
: The trial was conducted in accordance with International Conference on Harmonisation Good Clinical Practice (ICH GCP E6 (R2)) and applicable laws and regulations. The protocol was reviewed and approved by an Independent Ethics Committee (the Portuguese Ethics Committee for Clinical Research (CEIC), Lisboa, Portugal), and all participants provided written informed consent before any procedures were undertaken.
: Marlene Fonseca is an employee of BlueClinical Phase I, which was contracted by the sponsor to undertake this research. Gabriel Bauzà Valverde, Abdelkarim Bendarraz, Carmen Catalán Flores and Vikas Mohan Sharma are employees of the Scientific Department at Neuraxpharm.
